A Safety Study in Patients With Advanced Prostate Cancer Treated With FIRMAGON

NCT ID: NCT01234350

Last Updated: 2019-06-25

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1493 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-01-31

Study Completion Date

2018-03-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is a large observational study, set-up to observe how long-term treatment with FIRMAGON (hormone regulator) compare to other treatments in regards to cardiovascular events, changes in bone density, changes in blood sugar levels or liver enzyme levels in subjects with prostate cancer. Subjects will be treated according to their routine clinical care and not dictated by the study. As the study is observational in nature, the study will collect data relating to the events specified above. Subjects that agree to this study will be followed-up for 5 years. Subject data will be collected every 3 months for the first 2 years and every 6 months for the last 3 years.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Prostate Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

FIRMAGON

No interventions assigned to this group

GnRH Agonist

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosed with prostate cancer and indicated for androgen deprivation therapy (ADT)
* Decision made to prescribe ADT prior to enrolment
* Willing and able to provide written informed consent

Exclusion Criteria

* Participation in an interventional clinical study in which any treatment or follow-up is mandated
* Treatment with a GnRH receptor antagonist other than FIRMAGON
* Had previous or is currently under hormonal management of prostate cancer, except for subjects who have undergone therapy with curative intention where neoadjuvant/adjuvant therapy allowed for maximum 6 months. Treatment should be terminated at least 6 months prior to baseline.
Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ferring Pharmaceuticals

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Global Clinical Compliance

Role: STUDY_DIRECTOR

Ferring Pharmaceuticals

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Onze-Lieve-Vrouwziekenhuis

Aalst, , Belgium

Site Status

Ziekenhuisnetwerk Antwerpen - AZ Stuivenberg

Antwerp, , Belgium

Site Status

AZ Sint-Jan AV

Bruges, , Belgium

Site Status

Hôpitaux IRIS Sud

Brussels, , Belgium

Site Status

Université Catholique de Louvain

Brussels, , Belgium

Site Status

Hôpital Erasme

Bruxelle, , Belgium

Site Status

AZ Sint-Blasius

Dendermonde, , Belgium

Site Status

AZ Jan Palfijn

Ghent, , Belgium

Site Status

AZ Maria Middelares

Ghent, , Belgium

Site Status

AZ Sint-Lucas

Ghent, , Belgium

Site Status

UZ Gent

Ghent, , Belgium

Site Status

Regionaal Ziekenhuis Jan Yperman VZW

Ieper, , Belgium

Site Status

AZ Groeninge - Campus Sint-Maarten

Kortrijk, , Belgium

Site Status

CHU de Liège

Liège, , Belgium

Site Status

Centre Hospitalier Universitaire Ambroise Paré

Mons, , Belgium

Site Status

AZ Damiaan

Ostend, , Belgium

Site Status

AZ-Sint-Elizabeth VZW

Zottegem, , Belgium

Site Status

Aalborg Sygehus

Aalborg, , Denmark

Site Status

Rigshospitalet

Copenhagen, , Denmark

Site Status

Fredericia Hospital, Sygehus Lillebaelt

Fredericia, , Denmark

Site Status

Herlev Hospital

Herlev, , Denmark

Site Status

Holstebro Sygehus

Holstebro, , Denmark

Site Status

Regionhospitalet Viborg

Viborg, , Denmark

Site Status

Docrates clinic

Helsinki, , Finland

Site Status

Pohjois-Karjalan keskussairaala

Joensuu, , Finland

Site Status

Seinäjoen keskussairaala

Seinäjoki, , Finland

Site Status

Tampereen yliopistollinen sairaala

Tampere, , Finland

Site Status

Turun yliopistollinen keskussairaala

Turku, , Finland

Site Status

Peijaksen sairaala

Vantaa, , Finland

Site Status

CHRU Angers

Angers, , France

Site Status

Centre Hospitalier d'Athis Mons site Caron

Athis-Mons, , France

Site Status

Hopital Tenon

Aubervilliers, , France

Site Status

Clinique Rhone Durance

Avignon, , France

Site Status

CHU Saint-Jacques

Besançon, , France

Site Status

Centre Hospitalier Laennec

Clermont-Ferrand, , France

Site Status

Chu Gabriel Montpied

Clermont-Ferrand, , France

Site Status

Ramsay Sante

Évry, , France

Site Status

Groupement hospitalier Edouard Herriot

Lyon, , France

Site Status

Cabinet Médical 65 prado

Marseille, , France

Site Status

CHU Nord

Marseille, , France

Site Status

Hopital de la Conception

Marseille, , France

Site Status

Polyclinique Saint-Jean

Melun, , France

Site Status

Clinique du Pont de Chaume

Montauban, , France

Site Status

Clinique Beausoleil

Montpellier, , France

Site Status

Centre d'Urologie de Nancy

Nancy, , France

Site Status

Hôpital Max Fourestier

Nanterre, , France

Site Status

Centre Hospitalier Georges Renon

Niort, , France

Site Status

Groupe hospitalo-universitaire Caremeau

Nîmes, , France

Site Status

Hopital Tenon

Paris, , France

Site Status

Clinique du Ter

Ploemeur, , France

Site Status

Clinic De L'Europe

Pontoise, , France

Site Status

Hopital Pontchaillou

Rennes, , France

Site Status

Clinique Saint Michel

Toulon, , France

Site Status

Clinique St Jean Languedoc

Toulouse, , France

Site Status

Hopital Bretonneau

Tours, , France

Site Status

CHU Brabois

Vandœuvre-lès-Nancy, , France

Site Status

Gemeinschaftspraxis Dres Effert und Benedic

Aachen, , Germany

Site Status

Praxis Dr. Schlichter

Bad Bergzaben, , Germany

Site Status

Praxis Dr. Markus Hentschel

Bautzen, , Germany

Site Status

Praxis Dr. Richter

Bonn, , Germany

Site Status

Urologie im Schlosscarree

Braunschweig, , Germany

Site Status

Praxis Dr. Ahmad Haider

Bremerhaven, , Germany

Site Status

Praxis Dr. Krieger

Chemnitz, , Germany

Site Status

Urologie Chemnitz

Chemnitz, , Germany

Site Status

Praxis Dr. Thomas Harms

Cologne, , Germany

Site Status

Gemeinschaftspraxis fur Urologie

Dachau, , Germany

Site Status

Klinikpraxis fur Urologie

Dinslaken, , Germany

Site Status

Praxis Dr. Schönfelder

Hamburg, , Germany

Site Status

Gemeinschaftspraxis Urologie

Kiel, , Germany

Site Status

Urologische Gemeinschaftspraxis

Kiel, , Germany

Site Status

Gemeinshaftspraxis Rudolph & Wörner

Kirchheim, , Germany

Site Status

Vituro

Leipzig, , Germany

Site Status

Praxis Alexander von Keitz

Marburg, , Germany

Site Status

Praxis Dr. Peczat

Nienburg, , Germany

Site Status

Studienzentrum München-Planegg

Planegg, , Germany

Site Status

Urologische Gemeinschaftspraxis

Reutlingen, , Germany

Site Status

Praxis Dr. Jan Franz

Tostedt, , Germany

Site Status

Praxis fur Urologie

Wuppertal, , Germany

Site Status

"Agios Savas" Anticancer-Oncology Hospital of Athens

Athens, , Greece

Site Status

"G. Gennimtas" General Hospital of Athens

Athens, , Greece

Site Status

"Laiko" General Hospital of Athens

Athens, , Greece

Site Status

Amalia Fleming General Hospital of Athens

Athens, , Greece

Site Status

Errikos Dynan Hospital of Athens

Athens, , Greece

Site Status

Eurokliniki Hospital of Athens

Athens, , Greece

Site Status

Evaggelismos General Hospital

Athens, , Greece

Site Status

General Hospital of Athens "Ag. Olga" - Konstantopouleion

Athens, , Greece

Site Status

Ippokrateio Hospital of Athens

Athens, , Greece

Site Status

Korgialenio-Benakio

Athens, , Greece

Site Status

Pe. Pa.G.N:I Hospital

Heraklion, , Greece

Site Status

General hospital of Kalamata

Kalamata, , Greece

Site Status

IASO General Hospital

Kalamata, , Greece

Site Status

University Hospital of Larissa

Larissa, , Greece

Site Status

Aghios Andreas General Hospital of Patras

Pátrai, , Greece

Site Status

University General Hospital of Patras

Pátrai, , Greece

Site Status

General Hospital of Piraeus "Tzanneio"

Piraeus, , Greece

Site Status

"G. Gennimtas" General Hospital of Thessaloniki

Thessaloniki, , Greece

Site Status

2nd IKA-ETAM "Panagia" General Hospital of Thessaloniki

Thessaloniki, , Greece

Site Status

Papageorgiou General Hospital of Thessaloniki

Thessaloniki, , Greece

Site Status

General Hospital of Volos "Achillopouleio"

Volos, , Greece

Site Status

Azarka Zsuzsanna és Társa Bt

Budapest, , Hungary

Site Status

UROFOR Bt

Debrecen, , Hungary

Site Status

Kiskunhalasi Semmelweis Kórház Kht.

Kiskunhalas, , Hungary

Site Status

Miskolci Semmelweis Ignác Egészségügyi Központ és Egyetemi Oktató Kórház Nonprofit Kft

Miskolc, , Hungary

Site Status

Uro-Clin Kft

Pécs, , Hungary

Site Status

FEjér Megyei Szent György Kórhaz

Székesfehérvár, , Hungary

Site Status

Beacon Hospital

Dublin, , Ireland

Site Status

Beaumont Hospital

Dublin, , Ireland

Site Status

University College Hospital

Galway, , Ireland

Site Status

Medical Consulting Center S.r.l.

Avellino, , Italy

Site Status

Azienda Sanitaria Regionale del Molise (ASREM)

Campobasso, , Italy

Site Status

Azienda Ospedaliera Mater Domini di Catanzaro

Catanzaro, , Italy

Site Status

Azienda Ospedaliera Carlo Poma

Mantova, , Italy

Site Status

Ospedale Luigi Sacco

Milan, , Italy

Site Status

Azienda Ospedaliera Monaldi

Napoli, , Italy

Site Status

Azienda Sanitaria Locale Salerno

Nocera Inferiore, , Italy

Site Status

Ospedale Santa Maria delle Croci

Ravenna, , Italy

Site Status

Azienda Ospedaliera "Bianchi-Melacrino-Morelli"

Reggio Calabria, , Italy

Site Status

Istituto Nazionale Tumori "Regina Elena"

Roma, , Italy

Site Status

Azienda Ospedaliera Universitaria OO.RR. S.Giovanni di Dio e Ruggi d'Aragona

Salerno, , Italy

Site Status

ASL 4 di Teramo

Teramo, , Italy

Site Status

Ospedale "San Pio da Pietrelcina"

Vasto, , Italy

Site Status

AMC

Amsterdam, , Netherlands

Site Status

Catharina ziekenhuis

Eindhoven, , Netherlands

Site Status

Groene Hart Ziekenhuis

Gouda, , Netherlands

Site Status

Diaconessenhuis Leiden

Leiden, , Netherlands

Site Status

MC Haaglanden

The Hague, , Netherlands

Site Status

Vestre Viken HF, Sykehuset Asker og Baerum

Asker, , Norway

Site Status

Haukeland Universitetssykehus

Bergen, , Norway

Site Status

Helse Nordmore og Romsdal HF, Kristiansund Sykehus

Kristiansund, , Norway

Site Status

Olso Universitetssykehus HF, Radiumhospitalet

Oslo, , Norway

Site Status

Oslo Universitetssykehus, Aker

Oslo, , Norway

Site Status

Clinica de Santo Antonio

Lisbon, , Portugal

Site Status

Hospital Militar

Lisbon, , Portugal

Site Status

Hospital Santa Maria

Lisbon, , Portugal

Site Status

VEBMED, s.r.o.

Bošany, , Slovakia

Site Status

CUIMED, s.r.o.

Bratislava, , Slovakia

Site Status

Nemocnica Svateho Michala, a.s.

Bratislava, , Slovakia

Site Status

Univerzitna nemocnica Bratislava

Bratislava, , Slovakia

Site Status

URO clinic, s.r.o.

Bratislava, , Slovakia

Site Status

Poliklinika Galanta

Galanta, , Slovakia

Site Status

MEDICONA s.r.o.

Košice, , Slovakia

Site Status

UROCENTRUM LEVICE, s.r.o.

Levice, , Slovakia

Site Status

Poliklinika Malacky

Malacky, , Slovakia

Site Status

Univerzitna nemocnica Martin

Martin, , Slovakia

Site Status

UROEXAM, spol. s r.o.

Nitra, , Slovakia

Site Status

CENTRUM UROLOGIE Povazska Bystrica s.r.o

Považská Bystrica, , Slovakia

Site Status

MILAB, s.r.o.

Prešov, , Slovakia

Site Status

Nemocnica s poliklinikou Skalica, a.s.

Skalica, , Slovakia

Site Status

UROCENTRUM SALA, s.r.o.

Šaľa, , Slovakia

Site Status

M & M & M, s.r.o.

Topoľčany, , Slovakia

Site Status

PRIVATNA UROLOGICKA AMBULANCIA s.r.o.

Trenčín, , Slovakia

Site Status

UROREX, s.r.o.

Vráble, , Slovakia

Site Status

Universitätsspital Basel

Basel, , Switzerland

Site Status

Urozentrum Zürich

Zurich, , Switzerland

Site Status

Homerton University Hospital

London, , United Kingdom

Site Status

Kings College Hospital

London, , United Kingdom

Site Status

Royal Marsden Hospital

London, , United Kingdom

Site Status

Whipps Cross Hospital

London, , United Kingdom

Site Status

East Surrey Hospital

Redhill, , United Kingdom

Site Status

Sunderland Royal Hospital

Sunderland, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium Denmark Finland France Germany Greece Hungary Ireland Italy Netherlands Norway Portugal Slovakia Switzerland United Kingdom

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FE200486 CS39

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Firmagon (Degarelix) Intermittent Therapy
NCT01512472 TERMINATED PHASE4